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Background: Contrast induced acute kidney injury (CI-AKI) is an important complication of PCI. To assess reliably risk of CI-AKI, a previous simple 
risk score has been proposed that may be quickly calculated based on the readily available information. Whether this risk score is accurate in 
external datasets is not known.
Methods: CI-AKI risk score was previously developed on 5,571 pts treated with PCI from a database of a tertiary referral center. Multivariable 
logistic regression identified 8 independent predictors of CIN with p-value <0.0001; based on the odds ratio each risk factor was assigned a 
weighed integer; the sum of the integers was a total risk score for each pt. The database from the randomized ACUITY trial was used to validate this 
CI-AKI risk score. The same clinical and laboratory data were available for analysis, with the exception of information on hypotension and congestive 
heart failure. The predictive accuracy of the scoring system was examined by calculating Cochran Armitage test.
Results: In ACUITY, among 6,731 PCI pts with serial serum creatinine (sCr) measurements, CI-AKI (increase ≥25% and/or ≥0.5mg/dl in sCr at 
48 hours post-PCI compared to baseline) developed in 783 pts (11.6%). The rate of CI-AKI increased (Figure) with increasing risk score (Cochran 
Armitage p<0.0001).
Conclusion: The CI-AKI scoring system for risk stratification of pts undergoing PCI demonstrated good discriminating ability in external database of 
pts with ACS undergoing early invasive strategy.
 
